Home | PHARMAC
Home | PHARMAC
  • Website
  • Application Tracker
  • Schedule
  • About PHARMAC
    • About PHARMAC
    • Your guide to PHARMAC
    • Our history
    • Our people
    • Expert advice
    • PHARMAC's performance
    • Operating policies and procedures
    • Year in review 2017
    • Strategies
    • Consumer voice - review 2018
  • Medicines
    • Medicines
    • How medicines are funded
    • Medicines information
    • My medicine or medical device has changed
    • Your health
    • Hospital pharmaceuticals
    • New medicines – from development to funding
    • Equity
  • Hospital devices
    • Hospital devices
    • What's happening in each category?
    • PHARMAC's approach to hospital devices
    • Device Advice
    • PHARMAC medical devices forums 2017
  • News
  • Te Whaioranga
    • Te Whaioranga
    • Te Whaioranga 2013 - 2023: Māori Responsiveness Strategy
    • Whānau Ora
    • He Rongoā Pai, He Oranga Whānau
    • One Heart Many Lives
    • Scholarships
    • Hauora Arotahi - Māori health areas of focus
    • Māori Responsiveness Team
  • Pacific
    • Pacific
    • Pacific responsiveness strategy
    • Pacific action plan
  • Tools & resources
    • Tools & resources
    • Pharmaceutical Schedule
    • Annual Procurement Plan
    • Forms
    • Research
    • Print and PDF resources
    • Glossary
    • PHARMAC labelling preferences
  • Information for…

<< PHARMAC Services

Application Tracker

The Application Tracker aims to help people keep up to date with pharmaceutical funding applications PHARMAC is considering. New applications are added as we receive them.

The Application Tracker includes all applications received since 2008, and most applications received since 2002. Click to show/hide the remaining applications.


The following applications are not visible in the Application Tracker. All of them were received before 2008. Several have been superseded by later applications.

Trade (chemical) names Date Received Presentation Applicant
Durex Avanti (non-latex male condoms) September 2002 Packs of 5 Durex/SSL International Plc
Glucoval testing strips (blood glucose testing strips) April 2003 AFT Pharmaceuticals
Cubitan May 2003 Oral Supplements (200ml pack) Nutricia
Taxanes April 2004 Paclitaxel - 100 mg injection and 6 mg/ml solution for infusion. Docetaxel - 20mg and 80 mg injection and 20 mg / 0.5 ml and 40 mg/ml solution Clinicians
Paroxetine Mesylate April 2004 20mg AFT Pharmaceuticals
MabThera (Rituximab) June 2004 Single-use vials of 100 mg / 10ml and 500 mg / 50ml solution Clinicians
Oxaliplatin July 2004 Vials (50 mg and 100 mg) Sanofi-Synthelabo
Xeloda (capecitabine) May 2005 150mg, 500mg tablets (widening access) Roche Products (NZ) Limited
Symbicort (budesonide with efomoterol) July 2005 Dry Powder Inhaler 100/6 mcg, 200/6 mcg AstraZeneca
Enlive plus January 2006 Juice Style Adult oral supplement Abbott Nutrition

The Application Tracker tells you the key steps an application has been through, and also links you to relevant published PTAC minutes, subcommittee minutes, consultation letters, and related notifications.

You can search for applications by:

  • Chemical Name
  • Brand Name
  • Therapeutic Group, e.g. "Oncology and Immunosuppressants", "Special Foods"
  • Applicant
  • The condition funding is requested for

About this site

  • Sitemap
  • Copyright
  • Disclaimer
  • Privacy statement
  • This site is operated by PHARMAC, the Pharmaceutical Management Agency.

Contact

  • Contact us
  • Twitter - PHARMACnz
  • Facebook - PHARMACnz
  • YouTube - PHARMACgovtnz
  • LinkedIn - Pharmaceutical Management Agency (PHARMAC)
  • Careers
  • Newsfeed

Back to top

New Zealand Government